A Double-blind, Randomized, Placebo- and Active-controlled, Parallel-group Trial to Evaluate the Effect of Single-dose TMC207 on the QT/QTc Interval in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2012
At a glance
- Drugs Bedaquiline; Moxifloxacin
- Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
- Focus Adverse reactions
- 28 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Nov 2011 Actual initiation date changed from Mar 2011 to Feb 2011 as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.